FI109125B - Menetelmä risperidonin pamoaattiadditiosuolan valmistamiseksi - Google Patents

Menetelmä risperidonin pamoaattiadditiosuolan valmistamiseksi Download PDF

Info

Publication number
FI109125B
FI109125B FI955166A FI955166A FI109125B FI 109125 B FI109125 B FI 109125B FI 955166 A FI955166 A FI 955166A FI 955166 A FI955166 A FI 955166A FI 109125 B FI109125 B FI 109125B
Authority
FI
Finland
Prior art keywords
risperidone
pamoate
compounds
addition salt
preparing
Prior art date
Application number
FI955166A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI955166A0 (fi
FI955166A (fi
Inventor
Jean Louis Mesens
Jozef Peeters
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI955166A0 publication Critical patent/FI955166A0/fi
Publication of FI955166A publication Critical patent/FI955166A/fi
Application granted granted Critical
Publication of FI109125B publication Critical patent/FI109125B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/105—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
    • C07C65/11—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing two rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI955166A 1993-04-28 1995-10-27 Menetelmä risperidonin pamoaattiadditiosuolan valmistamiseksi FI109125B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP93201216 1993-04-28
EP93201216 1993-04-28
PCT/EP1994/001296 WO1994025460A1 (fr) 1993-04-28 1994-04-22 Pamoate de risperidone
EP9401296 1994-04-22

Publications (3)

Publication Number Publication Date
FI955166A0 FI955166A0 (fi) 1995-10-27
FI955166A FI955166A (fi) 1995-10-27
FI109125B true FI109125B (fi) 2002-05-31

Family

ID=8213799

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955166A FI109125B (fi) 1993-04-28 1995-10-27 Menetelmä risperidonin pamoaattiadditiosuolan valmistamiseksi

Country Status (32)

Country Link
US (2) US5612346A (fr)
EP (1) EP0697019B1 (fr)
JP (1) JP3478397B2 (fr)
KR (1) KR100307101B1 (fr)
CN (1) CN1041727C (fr)
AT (1) ATE163418T1 (fr)
AU (1) AU675136B2 (fr)
BG (1) BG62004B1 (fr)
CA (1) CA2160366C (fr)
CY (1) CY2107B1 (fr)
CZ (1) CZ286688B6 (fr)
DE (1) DE69408666T2 (fr)
DK (1) DK0697019T3 (fr)
ES (1) ES2113652T3 (fr)
FI (1) FI109125B (fr)
GR (1) GR3026028T3 (fr)
HK (1) HK1006059A1 (fr)
HU (1) HU218212B (fr)
IL (1) IL109448A (fr)
LV (1) LV12315B (fr)
NO (1) NO305083B1 (fr)
NZ (1) NZ266143A (fr)
PH (1) PH30476A (fr)
PL (1) PL182466B1 (fr)
RO (1) RO115955B1 (fr)
RU (1) RU2131428C1 (fr)
SG (1) SG47046A1 (fr)
SI (1) SI9420031B (fr)
SK (1) SK280589B6 (fr)
TW (1) TW376319B (fr)
WO (1) WO1994025460A1 (fr)
ZA (1) ZA942909B (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK282231B6 (sk) * 1993-11-19 2001-12-03 Janssen Pharmaceutica N. V. Farmaceutický prostriedok na liečenie psychotických porúch
US5453425A (en) * 1994-07-11 1995-09-26 Janssen Pharmaceutica N.V. Risperidone oral formulation
TW487572B (en) * 1996-05-20 2002-05-21 Janssen Pharmaceutica Nv Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
US6617321B2 (en) * 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
CZ300725B6 (cs) * 1997-09-30 2009-07-29 Eli Lilly And Company 2-Methylthienbenzodiazepinová formulace
UA72189C2 (uk) * 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
CA2344873A1 (fr) * 1998-09-30 2000-04-06 Eli Lilly And Company Formulation de 2-methyl-thieno-benzodiazepine
WO2000027849A2 (fr) * 1998-11-12 2000-05-18 Merck & Co., Inc. Polymorphes therapeutiques d'un agoniste inverse de gaba-a alpha-5 et formulations de pamoate de ceux-ci
FR2802101B1 (fr) 1999-12-10 2003-02-28 Aventis Pharma Sa Association de cymemazine et d'un neuroleptique atypique
US6770478B2 (en) * 2000-02-10 2004-08-03 The Regents Of The University Of California Erythrocytic cells and method for preserving cells
US6495164B1 (en) * 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
WO2002043766A1 (fr) * 2000-11-29 2002-06-06 Takeda Chemical Industries, Ltd. Compositions medicinales et leur procede de preparation
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
US20060148826A1 (en) * 2002-08-23 2006-07-06 Ashish Gogia Stable aqueous solutions of risperidone and methods for their preparation
KR20040034996A (ko) * 2002-10-18 2004-04-29 한미약품 주식회사 리스페리돈의 개선된 제조방법
EP1615923A1 (fr) * 2003-04-22 2006-01-18 Synthon B.V. Monochlorhydrates de risperidone
US6987111B2 (en) * 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
MXPA06004489A (es) * 2003-10-23 2006-06-20 Otsuka Pharma Co Ltd Formulacion y metodo de aripiprazol inyectable esteril de liberacion controlada.
WO2005053796A1 (fr) * 2003-12-02 2005-06-16 B & B Beheer Nv Utilisation d'antagonistes, d'agonistes inverses ou d'agonistes partiels d4 et 5ht2a,
US7884096B2 (en) * 2003-12-02 2011-02-08 Pharmaneuroboost N.V. Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
AU2005209310B2 (en) * 2004-01-29 2011-01-06 Neuromolecular, Inc. Combination of a NMDA receptor antagonist and a MAO-inhibitor or a GADPH-inhibitor for the treatment of central nervous system-related conditions
US7932249B2 (en) * 2005-01-05 2011-04-26 Eli Lilly And Company Olanzapine pamoate dihydrate
EP1695973A1 (fr) * 2005-02-24 2006-08-30 Neuro3D Sel d'Ocaperidone et composition pharmaceutique le contenant.
AR055099A1 (es) * 2005-07-28 2007-08-08 Alza Corp Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
EP2279727A3 (fr) * 2005-09-15 2011-10-05 Elan Pharma International Limited Formulations nanoparticulaires d'aripiprazole
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
JP2010531807A (ja) 2007-05-25 2010-09-30 トルマー セラピューティクス， インコーポレイテッド リスペリドン化合物の徐放送達製剤
TWI410255B (zh) * 2007-07-31 2013-10-01 Otsuka Pharma Co Ltd 阿立哌唑（Ａｒｉｐｉｐｒａｚｏｌｅ）懸浮液及冷凍乾燥調配物之製法
EP2234617B1 (fr) * 2007-12-19 2021-03-31 Janssen Pharmaceutica NV Schéma posologique associé à des esters de palipéridone injectables à action prolongée
EP2685979B1 (fr) 2011-03-18 2016-08-24 Alkermes Pharma Ireland Limited Compositions pharmaceutiques injectables comprenant un agent antipsychotique insoluble dans l'eau, du laurate de sorbitan et du polysorbate 20
EP2702060B1 (fr) * 2011-04-26 2015-12-30 Torrent Pharmaceuticals Limited Sels d'addition acide de risperidone et leurs compositions pharmaceutiques
WO2013142198A1 (fr) 2012-03-19 2013-09-26 Alkermes Pharma Ireland Limited Compositions pharmaceutiques comprenant des esters d'acides gras
JP6219918B2 (ja) 2012-03-19 2017-10-25 アルカームス ファーマ アイルランド リミテッド グリセロールエステルを含む医薬組成物
EP2827866B1 (fr) * 2012-03-19 2023-05-03 Alkermes Pharma Ireland Limited Compositions pharmaceutiques comprenant de l'alcool benzylique
JP6088637B2 (ja) 2012-04-04 2017-03-01 インターベット インターナショナル ベー． フェー． イソオキサゾリン化合物のための固形経口医薬組成物
CN102659577B (zh) * 2012-04-07 2014-07-02 安徽绩溪县徽煌化工有限公司 一种亚甲基双羟基萘酸的制备方法
WO2014080285A2 (fr) 2012-09-19 2014-05-30 Alkermes Pharma Ireland Limited Compositions pharmaceutiques ayant une plus grande stabilité au stockage
WO2014049071A1 (fr) 2012-09-26 2014-04-03 Tangent Reprofiling Limited Modulateurs de la synthèse d'androgènes
US9375433B2 (en) 2012-09-26 2016-06-28 Tangent Reprofiling Limited Modulators of androgen synthesis
US9452131B2 (en) 2014-03-20 2016-09-27 Alkermes Pharma Ireland Limited Aripiprazole formulations having increased injection speeds
CN106831594B (zh) * 2017-01-18 2018-02-02 力赛生物医药科技（厦门）有限公司 可乐定双羟萘酸盐及其制备方法
CN112423754A (zh) 2018-03-05 2021-02-26 奥克梅斯制药爱尔兰有限公司 阿立哌唑的给药策略

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles

Also Published As

Publication number Publication date
RU2131428C1 (ru) 1999-06-10
NZ266143A (en) 1996-07-26
SI9420031B (sl) 2002-08-31
US5612346A (en) 1997-03-18
PL311282A1 (en) 1996-02-05
HU218212B (hu) 2000-06-28
HUT72970A (en) 1996-06-28
NO954275L (no) 1995-10-26
ZA942909B (en) 1995-10-26
PH30476A (en) 1997-05-28
JP3478397B2 (ja) 2003-12-15
SK131395A3 (en) 1996-06-05
WO1994025460A1 (fr) 1994-11-10
CZ286688B6 (en) 2000-06-14
LV12315B (en) 2000-03-20
AU6721694A (en) 1994-11-21
IL109448A0 (en) 1994-07-31
FI955166A0 (fi) 1995-10-27
GR3026028T3 (en) 1998-04-30
CY2107B1 (en) 2002-04-26
LV12315A (lv) 1999-07-20
ATE163418T1 (de) 1998-03-15
FI955166A (fi) 1995-10-27
BG100094A (bg) 1996-05-31
DK0697019T3 (da) 1998-09-28
EP0697019B1 (fr) 1998-02-25
IL109448A (en) 1997-03-18
CZ270695A3 (en) 1996-01-17
HK1006059A1 (en) 1999-02-05
RO115955B1 (ro) 2000-08-30
DE69408666D1 (de) 1998-04-02
BG62004B1 (bg) 1998-12-30
CA2160366C (fr) 2006-06-06
NO954275D0 (no) 1995-10-26
CA2160366A1 (fr) 1994-11-10
CN1041727C (zh) 1999-01-20
JPH08509482A (ja) 1996-10-08
SI9420031A (en) 1996-08-31
AU675136B2 (en) 1997-01-23
US5723467A (en) 1998-03-03
HU9501934D0 (en) 1995-09-28
CN1121719A (zh) 1996-05-01
SK280589B6 (sk) 2000-04-10
PL182466B1 (pl) 2002-01-31
EP0697019A1 (fr) 1996-02-21
SG47046A1 (en) 1998-03-20
TW376319B (en) 1999-12-11
DE69408666T2 (de) 1998-06-18
KR100307101B1 (ko) 2001-11-30
ES2113652T3 (es) 1998-05-01
NO305083B1 (no) 1999-03-29

Similar Documents

Publication Publication Date Title
FI109125B (fi) Menetelmä risperidonin pamoaattiadditiosuolan valmistamiseksi
CA2626134C (fr) Derives de benzimidazolone utiles pour le traitement des troubles premenstruels et d'autres troubles sexuels chez la femme
EP0960106B1 (fr) Ligands de 1-phenyle-4-benzylpiperazines specifiques pour le sous-type du recepteur de dopamine (d4)
JP2010095550A (ja) キノリン誘導体
WO1993016698A1 (fr) FURO[3',4':6,7]INDOLIZINO[1,2-b]QUINOLINONES SUBSTITUEES
TW593302B (en) Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
US4663456A (en) 2-(substituted piperazinylalkyl)β-carbolines useful in treatment of psychological disorders
RU2281945C2 (ru) Мезилат 8-{4-[3-(5-фтор-1н-индол-3-ил) пропил] пиперазин-1-ил} -2-метил-4н-бензо[1,4] оксазин-3-он с высоким сродством к допаминовому рецептору d2 и сайту повторного поглощения серотонина
US20060069096A1 (en) Pyrazolo[3,4-e]benzoxazoles for the treatment of glaucoma
US3632653A (en) Ethano-anthracenes
KR20010086448A (ko) 벤즈옥사졸 유도체 및 유효 성분으로서 이를 포함하는 의약
IE42161B1 (en) Pyrano-quinoline carboxylic acids,processes for their preparation and their use as pharmaceutical agents
US4680297A (en) Tricyclic positive inotropic agents
WO2014066840A1 (fr) Inhibiteurs d'aurora kinase
HU204821B (en) Process for producing endo-n-braces open brackets open (8-methyl-8-azabicyclo/3,2,1/octan-3/yl)-amino brackets closed -carbonyl braces closed-2-(cyclopropylmethoxy)-benzamide, its salts and pharmaceutical compositions comprising such compounds as active ingredient
US7338972B1 (en) Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
EP0373658A2 (fr) Utilisation de dérivés de la quinoline pour le traitement du cancer
US5489607A (en) Use of enadoline in the treatment of benign prostatic enlargement
WO1995003803A1 (fr) FURO[3',4':6,7]INDOLIZINO[1,2-b]QUINOLINONES SUBSTITUEES
ITMI941462A1 (it) Derivati eterociclo-condensati di morfinoidi
DD150204A5 (de) Verfahren zur herstellung von [2,3-e]-as-triazin-derivaten
MXPA99007112A (en) 1-phenyl-4-benzylpiperazines:dopamine receptor subtype specific ligands (d4)

Legal Events

Date Code Title Description
MA Patent expired